Skip to main content

Table 2 Patient Characteristics

From: A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix

Median Age, year-old (range)

50.5 (34–62)

Performance status, n (%)

 

   0

13

   1

17

   2

0

FIGO stage

 

   IIa2

3

   IIb

20

   IIIb

7

Histology

 

 Squamous cell carcinoma

30

 Not Squamous cell carcinoma

0

Grade

 

   NC*

5

   1

1

   2

20

   3

4

  1. *NC: not confirmed.